Daclatasvir and asunaprevir treatment in patients infected by genotype 1b of hepatitis C virus with no or subtle resistant associated substitutions (RAS) in NS5A‐Y93

Publisher: John Wiley & Sons Inc

E-ISSN: 1096-9071|90|4|736-744

ISSN: 0146-6615

Source: JOURNAL OF MEDICAL VIROLOGY, Vol.90, Iss.4, 2018-04, pp. : 736-744

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract